应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
TSHA Taysha Gene Therapies, Inc.
交易中 11-05 15:56:14 EST
1.27
-0.07
-5.60%
最高
1.36
最低
1.19
成交量
1,184万
今开
1.34
昨收
1.34
日振幅
12.31%
总市值
2.59亿
流通市值
1.55亿
总股本
2.05亿
成交额
1,458万
换手率
9.68%
流通股本
1.22亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
北京优虎网络科技有限公司
资讯
新帖
简况
Taysha Gene Therapies, Inc.盘中异动 快速下跌5.16%
市场透视 · 11-05 01:24
Taysha Gene Therapies, Inc.盘中异动 快速下跌5.16%
Taysha Gene Therapies, Inc.盘中异动 股价大跌5.03%
市场透视 · 11-01
Taysha Gene Therapies, Inc.盘中异动 股价大跌5.03%
Taysha Gene Therapies, Inc.盘中异动 大幅下挫5.08%报1.78美元
市场透视 · 10-31
Taysha Gene Therapies, Inc.盘中异动 大幅下挫5.08%报1.78美元
Taysha Gene Therapies, Inc.盘中异动 早盘大幅下挫5.94%报1.90美元
市场透视 · 10-22
Taysha Gene Therapies, Inc.盘中异动 早盘大幅下挫5.94%报1.90美元
Taysha Gene Therapies, Inc.盘中异动 快速拉升5.13%
市场透视 · 10-16
Taysha Gene Therapies, Inc.盘中异动 快速拉升5.13%
Taysha Gene Therapies, Inc.盘中异动 早盘快速跳水5.12%
市场透视 · 09-23
Taysha Gene Therapies, Inc.盘中异动 早盘快速跳水5.12%
Taysha Gene Therapies, Inc.盘中异动 急速上涨5.35%报2.27美元
市场透视 · 09-19
Taysha Gene Therapies, Inc.盘中异动 急速上涨5.35%报2.27美元
Taysha Gene Therapies, Inc.盘中异动 大幅下跌5.02%报2.18美元
市场透视 · 09-17
Taysha Gene Therapies, Inc.盘中异动 大幅下跌5.02%报2.18美元
Taysha Gene Therapies, Inc.盘中异动 快速拉升5.02%报2.30美元
市场透视 · 09-14
Taysha Gene Therapies, Inc.盘中异动 快速拉升5.02%报2.30美元
Taysha Gene Therapies, Inc.盘中异动 急速下挫5.39%报2.20美元
市场透视 · 09-12
Taysha Gene Therapies, Inc.盘中异动 急速下挫5.39%报2.20美元
Taysha Gene Therapies, Inc.2024财年第二财季实现净利润-20.93百万美元,同比增加14.92%
自选股智能写手 · 08-19
Taysha Gene Therapies, Inc.2024财年第二财季实现净利润-20.93百万美元,同比增加14.92%
Taysha Gene Therapies, Inc.盘中异动 早盘股价大涨5.15%报2.15美元
自选股智能写手 · 08-13
Taysha Gene Therapies, Inc.盘中异动 早盘股价大涨5.15%报2.15美元
Taysha Gene Therapies, Inc.盘中异动 股价大涨5.26%报2.20美元
自选股智能写手 · 08-12
Taysha Gene Therapies, Inc.盘中异动 股价大涨5.26%报2.20美元
泰沙基因治疗公司公布截至 6 月的季度业绩 - 收益摘要
Reuters · 08-12
泰沙基因治疗公司公布截至 6 月的季度业绩 - 收益摘要
泰沙基因治疗公司 预计每股亏损16美分 - 财报前瞻
Reuters · 08-10
泰沙基因治疗公司 预计每股亏损16美分 - 财报前瞻
Taysha Gene Therapies, Inc.盘中异动 早盘快速下跌5.11%报2.04美元
自选股智能写手 · 08-07
Taysha Gene Therapies, Inc.盘中异动 早盘快速下跌5.11%报2.04美元
Taysha Gene Therapies, Inc.盘中异动 股价大涨5.20%
自选股智能写手 · 08-06
Taysha Gene Therapies, Inc.盘中异动 股价大涨5.20%
Taysha Gene Therapies, Inc.盘中异动 早盘股价大跌7.61%
自选股智能写手 · 08-05
Taysha Gene Therapies, Inc.盘中异动 早盘股价大跌7.61%
Taysha Gene Therapies, Inc.盘中异动 早盘股价大跌6.48%报2.02美元
自选股智能写手 · 08-02
Taysha Gene Therapies, Inc.盘中异动 早盘股价大跌6.48%报2.02美元
Taysha Gene Therapies, Inc.盘中异动 早盘股价大跌5.22%报2.18美元
自选股智能写手 · 07-29
Taysha Gene Therapies, Inc.盘中异动 早盘股价大跌5.22%报2.18美元
加载更多
公司概况
公司名称:
Taysha Gene Therapies, Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Taysha Gene Therapies, Inc.最初是根据德克萨斯州法律于2019年9月20日成立。该公司于2020年2月13日转换为特拉华州公司。该公司是一家以患者为中心的基因治疗公司,致力于开发和开发商业化基于AAV的基因疗法,用于治疗罕见和大量患者群体的中枢神经系统单基因疾病。
发行价格:
--
{"stockData":{"symbol":"TSHA","market":"US","secType":"STK","nameCN":"Taysha Gene Therapies, Inc.","latestPrice":1.265,"timestamp":1730840174022,"preClose":1.34,"halted":0,"volume":11837451,"delay":0,"floatShares":122283583,"shares":204943306,"eps":-0.570928,"marketStatus":"交易中","marketStatusCode":2,"change":-0.075,"latestTime":"11-05 15:56:14 EST","open":1.34,"high":1.355,"low":1.19,"amount":14579768.1671895,"amplitude":0.123134,"askPrice":1.27,"askSize":6153,"bidPrice":1.26,"bidSize":13134,"shortable":0,"etf":0,"ttmEps":-0.570928,"exchange":"NASDAQ","tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1730840400000},"adr":0,"listingDate":1600920000000,"adjPreClose":1.34,"preHourTrading":{"tag":"盘前","latestPrice":1.36,"preClose":1.34,"latestTime":"09:18 EST","volume":9456,"amount":12790.4777904,"timestamp":1730816323187},"postHourTrading":{"tag":"盘后","latestPrice":1.3496,"preClose":1.34,"latestTime":"19:58 EST","volume":49829,"amount":66747.5854,"timestamp":1730768293551},"volumeRatio":3.094826,"impliedVol":3.7318,"impliedVolPercentile":0.9762},"requestUrl":"/m/hq/s/TSHA","defaultTab":"news","newsList":[{"id":"2481203531","title":"Taysha Gene Therapies, Inc.盘中异动 快速下跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481203531","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481203531?lang=zh_cn&edition=full","pubTime":"2024-11-05 01:24","pubTimestamp":1730741048,"startTime":"0","endTime":"0","summary":"北京时间2024年11月05日01时24分,Taysha Gene Therapies, Inc.股票出现波动,股价快速跳水5.16%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体跌幅为0.07%。其相关个股中,Neurogene Inc.、Tenaya Therapeutics, Inc.、Disc Medicine, Inc.涨幅较大,Elevai Labs, Inc.、Nls Pharmaceutics Ltd.、Gri Bio, Inc.较为活跃,换手率分别为352.15%、274.99%、79.03%,振幅较大的相关个股有Sab Biotherapeutics Inc C/Wts 22/10/2026 、In8Bio, Inc.、Kazia Therapeutics Limited,振幅分别为52.25%、45.39%、39.13%。Taysha Gene Therapies, Inc.公司简介:Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司,旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105012408a21595aa&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241105012408a21595aa&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2480835020","title":"Taysha Gene Therapies, Inc.盘中异动 股价大跌5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2480835020","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480835020?lang=zh_cn&edition=full","pubTime":"2024-11-01 23:46","pubTimestamp":1730476007,"startTime":"0","endTime":"0","summary":"北京时间2024年11月01日23时46分,Taysha Gene Therapies, Inc.股票出现异动,股价急速下跌5.03%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体涨幅为0.56%。其相关个股中,Revolution Medicines Inc C/Wts 17/12/2026 、Athira Pharma, Inc.、Tc Biopharm Plc C/Wts 10/02/2028 涨幅较大,Theriva Biologics, Inc.、Gri Bio, Inc.、Ensysce Biosciences, Inc.较为活跃,换手率分别为3442.74%、830.74%、776.54%,振幅较大的相关个股有Klotho Neurosciences Inc C/Wts 21/06/2029 、Tc Biopharm Plc C/Wts 10/02/2028 、Immatics N V C/Wts 01/07/2025 ,振幅分别为122.67%、96.49%、60.77%。Taysha Gene Therapies, Inc.公司简介:Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司,旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110123464898e400cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024110123464898e400cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2479038173","title":"Taysha Gene Therapies, Inc.盘中异动 大幅下挫5.08%报1.78美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2479038173","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479038173?lang=zh_cn&edition=full","pubTime":"2024-10-31 21:49","pubTimestamp":1730382559,"startTime":"0","endTime":"0","summary":"北京时间2024年10月31日21时49分,Taysha Gene Therapies, Inc.股票出现异动,股价大幅跳水5.08%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体跌幅为2.37%。其相关个股中,Psyence Biomedical Ltd C/Wts 25/01/2029、Ocean Biomedical Inc C/Wts 14/02/2028 、Aerovate Therapeutics, Inc.涨幅较大,Evogene Ltd.、Aditxt, Inc.、Palisade Bio, Inc.较为活跃,换手率分别为210.69%、200.76%、152.88%,振幅较大的相关个股有Cingulate Inc C/Wts 10/12/2026 、Psyence Biomedical Ltd C/Wts 25/01/2029、180 Life Sciences Corp C/Wts 07/11/2025,振幅分别为39.30%、28.17%、21.98%。Taysha Gene Therapies, Inc.公司简介:Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司,旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031214919971a38b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241031214919971a38b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2477307203","title":"Taysha Gene Therapies, Inc.盘中异动 早盘大幅下挫5.94%报1.90美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2477307203","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2477307203?lang=zh_cn&edition=full","pubTime":"2024-10-22 22:02","pubTimestamp":1729605777,"startTime":"0","endTime":"0","summary":"北京时间2024年10月22日22时02分,Taysha Gene Therapies, Inc.股票出现异动,股价大幅下挫5.94%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体跌幅为0.85%。其相关个股中,Ensysce Biosciences, Inc.、Genprex, Inc.、Aptevo Therapeutics Inc.涨幅较大,Genprex, Inc.、Ensysce Biosciences, Inc.、Tc Biopharm Plc较为活跃,换手率分别为3607.22%、2333.71%、1760.16%,振幅较大的相关个股有Ensysce Biosciences, Inc.、Aptevo Therapeutics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029,振幅分别为140.78%、99.41%、67.84%。Taysha Gene Therapies, Inc.公司简介:Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司,旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022220257971a19e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241022220257971a19e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2475017914","title":"Taysha Gene Therapies, Inc.盘中异动 快速拉升5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2475017914","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2475017914?lang=zh_cn&edition=full","pubTime":"2024-10-16 23:12","pubTimestamp":1729091523,"startTime":"0","endTime":"0","summary":"北京时间2024年10月16日23时12分,Taysha Gene Therapies, Inc.股票出现波动,股价快速上涨5.13%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体跌幅为0.62%。其相关个股中,180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025、Korro Bio, Inc.涨幅较大,180 Life Sciences Corp.、Biodexa Pharmaceuticals Plc、Quoin Pharmaceuticals Ltd较为活跃,换手率分别为5892.71%、1063.64%、423.92%,振幅较大的相关个股有180 Life Sciences Corp.、180 Life Sciences Corp C/Wts 07/11/2025、Korro Bio, Inc.,振幅分别为623.68%、279.52%、126.58%。Taysha Gene Therapies, Inc.公司简介:Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司,旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101623120398e3ccfd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024101623120398e3ccfd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2469917146","title":"Taysha Gene Therapies, Inc.盘中异动 早盘快速跳水5.12%","url":"https://stock-news.laohu8.com/highlight/detail?id=2469917146","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2469917146?lang=zh_cn&edition=full","pubTime":"2024-09-23 23:06","pubTimestamp":1727104006,"startTime":"0","endTime":"0","summary":"北京时间2024年09月23日23时06分,Taysha Gene Therapies, Inc.股票出现波动,股价急速跳水5.12%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体跌幅为1.11%。其相关个股中,Tevogen Bio Holdings Inc C/Wts 14/02/2029 、Cingulate Inc C/Wts 10/12/2026 、Neurosense Therapeutics Ltd C/Wts 10/11/2026 涨幅较大,Galmed Pharmaceuticals Ltd.、Elevai Labs, Inc.、Novabay Pharmaceuticals, Inc.较为活跃,换手率分别为251.48%、46.60%、44.30%,振幅较大的相关个股有Briacell Therapeutics Corp C/Wts 24/02/2025、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Black Diamond Therapeutics, Inc.,振幅分别为42.83%、42.78%、25.84%。Taysha Gene Therapies, Inc.公司简介:Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司,旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923230646a1dbf07f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240923230646a1dbf07f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2468046725","title":"Taysha Gene Therapies, Inc.盘中异动 急速上涨5.35%报2.27美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468046725","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468046725?lang=zh_cn&edition=full","pubTime":"2024-09-19 23:38","pubTimestamp":1726760281,"startTime":"0","endTime":"0","summary":"北京时间2024年09月19日23时38分,Taysha Gene Therapies, Inc.股票出现异动,股价急速拉升5.35%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体涨幅为1.70%。其相关个股中,Exicure, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Edgewise Therapeutics, Inc.涨幅较大,Galmed Pharmaceuticals Ltd.、Exicure, Inc.、Portage Biotech Inc.较为活跃,换手率分别为4293.69%、808.73%、184.51%,振幅较大的相关个股有Exicure, Inc.、Galmed Pharmaceuticals Ltd.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025,振幅分别为101.31%、78.69%、52.97%。Taysha Gene Therapies, Inc.公司简介:Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司,旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919233801ab64a74c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240919233801ab64a74c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2468847698","title":"Taysha Gene Therapies, Inc.盘中异动 大幅下跌5.02%报2.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2468847698","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468847698?lang=zh_cn&edition=full","pubTime":"2024-09-17 00:11","pubTimestamp":1726503078,"startTime":"0","endTime":"0","summary":"北京时间2024年09月17日00时11分,Taysha Gene Therapies, Inc.股票出现异动,股价快速跳水5.02%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体跌幅为0.08%。其相关个股中,Nucana Plc、Surrozen Inc C/Wts 01/08/2031 、Tevogen Bio Holdings Inc C/Wts 14/02/2029 涨幅较大,Nucana Plc、Dermata Therapeutics, Inc.、Exicure, Inc.较为活跃,换手率分别为1905.62%、1600.81%、966.74%,振幅较大的相关个股有Psyence Biomedical Ltd C/Wts 25/01/2029、Nucana Plc、Tc Biopharm Plc C/Wts 10/02/2028 ,振幅分别为117.33%、69.69%、47.50%。Taysha Gene Therapies, Inc.公司简介:Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司,旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240917001118ab64041a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240917001118ab64041a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2467170335","title":"Taysha Gene Therapies, Inc.盘中异动 快速拉升5.02%报2.30美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2467170335","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2467170335?lang=zh_cn&edition=full","pubTime":"2024-09-14 00:21","pubTimestamp":1726244486,"startTime":"0","endTime":"0","summary":"北京时间2024年09月14日00时21分,Taysha Gene Therapies, Inc.股票出现波动,股价快速拉升5.02%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体跌幅为0.12%。其相关个股中,Conduit Pharmaceuticals Inc C/Wts 22/09/2028、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Instil Bio, Inc.涨幅较大,Windtree Therapeutics, Inc.、Immuneering Corporation、Galmed Pharmaceuticals Ltd.较为活跃,换手率分别为902.20%、407.46%、110.48%,振幅较大的相关个股有Instil Bio, Inc.、Immuneering Corporation、Neurosense Therapeutics Ltd C/Wts 10/11/2026 ,振幅分别为52.63%、51.75%、48.21%。Taysha Gene Therapies, Inc.公司简介:Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司,旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409140021269719b567&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202409140021269719b567&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2466970204","title":"Taysha Gene Therapies, Inc.盘中异动 急速下挫5.39%报2.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2466970204","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466970204?lang=zh_cn&edition=full","pubTime":"2024-09-12 23:01","pubTimestamp":1726153272,"startTime":"0","endTime":"0","summary":"北京时间2024年09月12日23时01分,Taysha Gene Therapies, Inc.股票出现波动,股价大幅下挫5.39%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体涨幅为0.64%。其相关个股中,Monopar Therapeutics Inc.、Estrella Immunopharma, Inc.、Instil Bio, Inc.涨幅较大,Monopar Therapeutics Inc.、Protagenic Therapeutics, Inc.、Kazia Therapeutics Limited较为活跃,换手率分别为961.88%、221.73%、57.55%,振幅较大的相关个股有Monopar Therapeutics Inc.、Briacell Therapeutics Corp C/Wts 24/02/2025、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025,振幅分别为84.61%、77.04%、59.26%。Taysha Gene Therapies, Inc.公司简介:Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司,旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240912230112ab635eae&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240912230112ab635eae&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2460710858","title":"Taysha Gene Therapies, Inc.2024财年第二财季实现净利润-20.93百万美元,同比增加14.92%","url":"https://stock-news.laohu8.com/highlight/detail?id=2460710858","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2460710858?lang=zh_cn&edition=full","pubTime":"2024-08-19 00:02","pubTimestamp":1723996954,"startTime":"0","endTime":"0","summary":"8月19日,Taysha Gene Therapies, Inc.公布财报,公告显示公司2024财年第二财季净利润为-20.93百万美元,同比增加14.92%;其中营业收入为1.11百万美元,同比减少53.75%,每股基本收益为-0.09美元。机构评级:截至2024年8月19日,当前有11家机构对Taysha Gene Therapies, Inc.目标价做出预测,其中目标均价为6.41美元,其中最低目标价为5.00美元,最高目标价为8.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081900024595a38552&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081900024595a38552&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA"],"gpt_icon":0},{"id":"2459390459","title":"Taysha Gene Therapies, Inc.盘中异动 早盘股价大涨5.15%报2.15美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2459390459","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2459390459?lang=zh_cn&edition=full","pubTime":"2024-08-13 21:56","pubTimestamp":1723557394,"startTime":"0","endTime":"0","summary":"北京时间2024年08月13日21时56分,Taysha Gene Therapies, Inc.股票出现波动,股价大幅拉升5.15%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体涨幅为0.76%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Cardio Diagnostics Holdings Inc C/Wts To Pur Com、冠科美博涨幅较大,Genprex, Inc.、冠科美博、Oragenics Inc.较为活跃,换手率分别为123.90%、87.83%、22.00%,振幅较大的相关个股有冠科美博、Coeptis Therapeutics Holdings Inc C/Wts 31/12/2024 、180 Life Sciences Corp C/Wts 07/11/2025,振幅分别为45.17%、33.11%、32.58%。Taysha Gene Therapies, Inc.公司简介:Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司,旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081321563594200472&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024081321563594200472&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0},{"id":"2458986255","title":"Taysha Gene Therapies, Inc.盘中异动 股价大涨5.26%报2.20美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2458986255","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458986255?lang=zh_cn&edition=full","pubTime":"2024-08-12 21:31","pubTimestamp":1723469483,"startTime":"0","endTime":"0","summary":"北京时间2024年08月12日21时31分,Taysha Gene Therapies, Inc.股票出现波动,股价大幅拉升5.26%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体跌幅为0.44%。其相关个股中,Revance Therapeutics, Inc.、Reviva Pharmaceuticals Holdings Inc C/Wts 25/12/2025、Oragenics Inc.涨幅较大,60 Degrees Pharmaceuticals, Inc.、Revance Therapeutics, Inc.、Altamira Therapeutics Ltd.较为活跃,换手率分别为36.27%、18.87%、8.53%,振幅较大的相关个股有Sangamo Therapeutics, Inc.、Oragenics Inc.、Azitra Inc,振幅分别为21.57%、13.93%、12.38%。Taysha Gene Therapies, Inc.公司简介:Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司,旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408122131239420002b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202408122131239420002b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2458003836","title":"泰沙基因治疗公司公布截至 6 月的季度业绩 - 收益摘要","url":"https://stock-news.laohu8.com/highlight/detail?id=2458003836","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458003836?lang=zh_cn&edition=full","pubTime":"2024-08-12 20:44","pubTimestamp":1723466659,"startTime":"0","endTime":"0","summary":" * Taysha Gene Therapies Inc 报告,截至6月底的季度调整后每股亏损9美分,高于去年同期的每股-38美分。11 位分析师对该季度的平均预期是每股亏损 16 美分。华尔街预期为每股-80美分至-8美分。* 营收同比下降 53.6%,为 111 万美元;分析师预期为 266 万美元。* Taysha Gene Therapies Inc公布的本季度每股收益为亏损9美分。* 该公司当季亏损 2093 万美元。* Taysha Gene Therapies Inc 本季度股价下跌了 6.7%,今年迄今为止上涨了 18.1%。华尔街对 Taysha Gene Therapies Inc 的 12 个月目标价中位数为 7.00 美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"泰沙基因治疗公司公布截至 6 月的季度业绩 - 收益摘要","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSHA"],"gpt_icon":0},{"id":"2458551540","title":"泰沙基因治疗公司 预计每股亏损16美分 - 财报前瞻","url":"https://stock-news.laohu8.com/highlight/detail?id=2458551540","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2458551540?lang=zh_cn&edition=full","pubTime":"2024-08-10 00:20","pubTimestamp":1723220416,"startTime":"0","endTime":"0","summary":" * 泰沙基因治疗公司 将于8月12日公布截至2024年6月30日的财报,预计季度收入将有所增长。* LSEG 分析师对 Taysha Gene Therapies Inc 的平均预期是每股亏损 16 美分。* 华尔街对 Taysha Gene Therapies Inc 的 12 个月目标价中位数为 7.00 美元,高于其上次收盘价 2.10 美元。8月9日 - 上一季度业绩。除非另有说明,否则所有数据均以美元为单位。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"泰沙基因治疗公司 预计每股亏损16美分 - 财报前瞻","news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TSHA"],"gpt_icon":0},{"id":"2457847063","title":"Taysha Gene Therapies, Inc.盘中异动 早盘快速下跌5.11%报2.04美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2457847063","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457847063?lang=zh_cn&edition=full","pubTime":"2024-08-07 22:30","pubTimestamp":1723041059,"startTime":"0","endTime":"0","summary":"北京时间2024年08月07日22时30分,Taysha Gene Therapies, Inc.股票出现波动,股价大幅下挫5.11%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体跌幅为1.82%。其相关个股中,Aditxt, Inc.、G1 Therapeutics, Inc.、Tc Biopharm Plc C/Wts 10/02/2028 涨幅较大,Aditxt, Inc.、Salarius Pharmaceuticals, Inc.、Scorpius Holdings, Inc.较为活跃,换手率分别为2259.46%、558.39%、326.10%,振幅较大的相关个股有Aditxt, Inc.、Tc Biopharm Plc C/Wts 10/02/2028 、Salarius Pharmaceuticals, Inc.,振幅分别为76.23%、69.66%、47.31%。Taysha Gene Therapies, Inc.公司简介:Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司,旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807223059aefdbc17&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240807223059aefdbc17&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2457021947","title":"Taysha Gene Therapies, Inc.盘中异动 股价大涨5.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457021947","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457021947?lang=zh_cn&edition=full","pubTime":"2024-08-06 22:48","pubTimestamp":1722955693,"startTime":"0","endTime":"0","summary":"北京时间2024年08月06日22时48分,Taysha Gene Therapies, Inc.股票出现异动,股价急速拉升5.20%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体涨幅为2.16%。其相关个股中,Vbi Vaccines, Inc.、Alpha Tau Medical Ltd C/Wts 、Sangamo Therapeutics, Inc.涨幅较大,Tenax Therapeutics, Inc.、Vbi Vaccines, Inc.、Cns Pharmaceuticals, Inc.较为活跃,换手率分别为1169.84%、1055.54%、348.09%,振幅较大的相关个股有Vbi Vaccines, Inc.、Alpha Tau Medical Ltd C/Wts 、Anew Medical Inc C/Wts 21/06/2029 ,振幅分别为168.52%、78.49%、72.21%。Taysha Gene Therapies, Inc.公司简介:Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司,旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806224813aefd87ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240806224813aefd87ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2457773424","title":"Taysha Gene Therapies, Inc.盘中异动 早盘股价大跌7.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2457773424","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2457773424?lang=zh_cn&edition=full","pubTime":"2024-08-05 21:33","pubTimestamp":1722864794,"startTime":"0","endTime":"0","summary":"北京时间2024年08月05日21时33分,Taysha Gene Therapies, Inc.股票出现波动,股价大幅跳水7.61%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体跌幅为1.67%。其相关个股中,Zevra Therapeutics, Inc.、Alzamend Neuro, Inc.、Cns Pharmaceuticals, Inc.涨幅较大,Cns Pharmaceuticals, Inc.、Dermata Therapeutics, Inc.、Senti Biosciences, Inc.较为活跃,换手率分别为983.82%、35.96%、13.54%,振幅较大的相关个股有Vor Biopharma Inc.、Compass Therapeutics, Inc.、Conduit Pharmaceuticals Inc.,振幅分别为13.04%、12.19%、11.60%。Taysha Gene Therapies, Inc.公司简介:Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司,旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213314957f2ec4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240805213314957f2ec4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2456289489","title":"Taysha Gene Therapies, Inc.盘中异动 早盘股价大跌6.48%报2.02美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2456289489","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2456289489?lang=zh_cn&edition=full","pubTime":"2024-08-02 21:31","pubTimestamp":1722605485,"startTime":"0","endTime":"0","summary":"北京时间2024年08月02日21时31分,Taysha Gene Therapies, Inc.股票出现波动,股价大幅下挫6.48%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体跌幅为0.74%。其相关个股中,Exicure, Inc.、Anew Medical Inc C/Wts 21/06/2029 、Os Therapies Incorporated涨幅较大,Exicure, Inc.、Dermata Therapeutics, Inc.、Cns Pharmaceuticals, Inc.较为活跃,换手率分别为220.96%、42.79%、16.70%,振幅较大的相关个股有Nuvation Bio Inc.、Xencor, Inc.、Exicure, Inc.,振幅分别为9.01%、8.12%、8.08%。Taysha Gene Therapies, Inc.公司简介:Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司,旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213126968233ba&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240802213126968233ba&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","TSHA"],"gpt_icon":0},{"id":"2455080662","title":"Taysha Gene Therapies, Inc.盘中异动 早盘股价大跌5.22%报2.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2455080662","media":"自选股智能写手","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2455080662?lang=zh_cn&edition=full","pubTime":"2024-07-29 23:14","pubTimestamp":1722266050,"startTime":"0","endTime":"0","summary":"北京时间2024年07月29日23时14分,Taysha Gene Therapies, Inc.股票出现波动,股价急速下跌5.22%。Taysha Gene Therapies, Inc.股票所在的生物技术行业中,整体涨幅为0.16%。其相关个股中,Lipella Pharmaceuticals Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Nls Pharmaceutics Ltd.涨幅较大,Lipella Pharmaceuticals Inc.、Salarius Pharmaceuticals, Inc.、Nls Pharmaceutics Ltd.较为活跃,换手率分别为2088.90%、682.46%、210.40%,振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Nls Pharmaceutics Ltd.、Anew Medical Inc C/Wts 21/06/2029 ,振幅分别为151.15%、75.11%、57.78%。Taysha Gene Therapies, Inc.公司简介:Taysha Gene Therapies Inc是一家以患者为中心的基因治疗公司,旨在消除单基因CNS疾病。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729231410af94a4cd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20240729231410af94a4cd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["TSHA","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.tayshagtx.com","stockEarnings":[{"period":"1week","weight":-0.3198},{"period":"1month","weight":-0.3333},{"period":"3month","weight":-0.3767},{"period":"6month","weight":-0.437},{"period":"1year","weight":-0.4597},{"period":"ytd","weight":-0.2429}],"compareEarnings":[{"period":"1week","weight":-0.019},{"period":"1month","weight":-0.0055},{"period":"3month","weight":0.0913},{"period":"6month","weight":0.1017},{"period":"1year","weight":0.3108},{"period":"ytd","weight":0.1988}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Taysha Gene Therapies, Inc.最初是根据德克萨斯州法律于2019年9月20日成立。该公司于2020年2月13日转换为特拉华州公司。该公司是一家以患者为中心的基因治疗公司,致力于开发和开发商业化基于AAV的基因疗法,用于治疗罕见和大量患者群体的中枢神经系统单基因疾病。","yearOnYearQuotes":[{"month":1,"riseRate":0,"avgChangeRate":-0.188381},{"month":2,"riseRate":0.25,"avgChangeRate":0.120073},{"month":3,"riseRate":0.25,"avgChangeRate":-0.121311},{"month":4,"riseRate":0.25,"avgChangeRate":-0.087217},{"month":5,"riseRate":0.25,"avgChangeRate":-0.029549},{"month":6,"riseRate":0.25,"avgChangeRate":-0.00003},{"month":7,"riseRate":0.5,"avgChangeRate":-0.021321},{"month":8,"riseRate":0.75,"avgChangeRate":0.9233},{"month":9,"riseRate":0,"avgChangeRate":-0.14195},{"month":10,"riseRate":0,"avgChangeRate":-0.151796},{"month":11,"riseRate":0.4,"avgChangeRate":-0.050531},{"month":12,"riseRate":0.75,"avgChangeRate":0.024785}],"exchange":"NASDAQ","name":"Taysha Gene Therapies, Inc.","nameEN":"Taysha Gene Therapies, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Taysha Gene Therapies, Inc.(TSHA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Taysha Gene Therapies, Inc.(TSHA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Taysha Gene Therapies, Inc.,TSHA,Taysha Gene Therapies, Inc.股票,Taysha Gene Therapies, Inc.股票老虎,Taysha Gene Therapies, Inc.股票老虎国际,Taysha Gene Therapies, Inc.行情,Taysha Gene Therapies, Inc.股票行情,Taysha Gene Therapies, Inc.股价,Taysha Gene Therapies, Inc.股市,Taysha Gene Therapies, Inc.股票价格,Taysha Gene Therapies, Inc.股票交易,Taysha Gene Therapies, Inc.股票购买,Taysha Gene Therapies, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Taysha Gene Therapies, Inc.(TSHA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Taysha Gene Therapies, Inc.(TSHA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}